J&J Innovative Medicine

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.

Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.

The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world’s second largest outbreak of the disease.

Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

The company just released its inaugural Diversity & Inclusion Impact Review. We take a look inside its pages to see how the company’s striving every day to build a culture of belonging.

As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.

Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.